Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Assets (2016 - 2025)

Historic Return on Assets for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.07%.

  • Haemonetics' Return on Assets rose 200.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.07% for FY2025, which is 200.0% up from last year.
  • Latest data reveals that Haemonetics reported Return on Assets of 0.07% as of Q4 2025, which was up 200.0% from 0.07% recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Return on Assets registered a high of 0.07% during Q4 2025, and its lowest value of 0.01% during Q1 2022.
  • In the last 5 years, Haemonetics' Return on Assets had a median value of 0.05% in 2022 and averaged 0.05%.
  • Within the past 5 years, the most significant YoY rise in Haemonetics' Return on Assets was 400bps (2022), while the steepest drop was -700bps (2022).
  • Over the past 5 years, Haemonetics' Return on Assets (Quarter) stood at 0.02% in 2021, then soared by 195bps to 0.05% in 2022, then increased by 18bps to 0.06% in 2023, then dropped by -14bps to 0.05% in 2024, then soared by 38bps to 0.07% in 2025.
  • Its Return on Assets stands at 0.07% for Q4 2025, versus 0.07% for Q3 2025 and 0.07% for Q2 2025.